INVA logo

Innoviva (INVA) Depreciation And Amortization

Annual D&A

$21.78 M
+$16.20 M+290.32%

December 31, 2023

Summary

Performance

1-Year Change

+290.32%

3-Year Change

+100%

5-Year Change

+57.04%

15-Year Change

+55.8%

INVA Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

80.02%
INVA annual depreciation & amortization is higher than 80.02% of companies in Healthcare sector

High & Low

All-time High

$21.78 M
INVA annual depreciation & amortization is currently at an all-time high

3-Year Low

$0.00
INVA annual depreciation & amortization is currently >+9900.00% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
INVA previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
INVA next annual earnings announcement is scheduled for Feb 28, 2025

Related metrics

Annual Total Expenses

$196.58 M
INVA annual total expenses is $196.58 million

Annual Operating Expenses

$153.94 M
INVA annual total operating expenses is $153.94 million

Annual Cost Of Goods Sold

$42.64 M
INVA annual cost of goods sold is $42.64 million

Annual Interest Expense

$19.16 M
INVA annual interest expense is $19.16 million

Quarterly D&A

$6.51 M
+$71.00 K+1.10%

September 1, 2024

Summary

Performance

3-Month Change

+1.1%

1-Year Change

0%

3-Year Change

+162.75%

5-Year Change

+96.11%

INVA Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

81.11%
INVA quarterly depreciation & amortization is higher than 81.11% of companies in Healthcare sector

High & Low

All-time High

$6.51 M
INVA quarterly depreciation & amortization is currently at an all-time high

3-Year Low

-$10.38 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
INVA previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
INVA next earnings announcement is scheduled for Feb 28, 2025

Related metrics

Quarterly Total Expenses

$46.27 M
INVA quarterly total expenses is $46.27 million

Quarterly Operating Expenses

$36.28 M
INVA quarterly total operating expenses is $36.28 million

Quarterly Cost Of Goods Sold

$9.99 M
INVA quarterly cost of goods sold is $9.99 million

Quarterly Interest Expense

$5.81 M
INVA quarterly interest expense is $5.81 million

TTM D&A

$25.90 M
$0.000.00%

September 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+33.9%

3-Year Change

+100%

5-Year Change

+87.72%

INVA TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

80.83%
INVA TTM depreciation & amortization is higher than 80.83% of companies in Healthcare sector

High & Low

All-time High

$25.90 M
INVA TTM depreciation & amortization is currently at an all-time high

3-Year Low

-$8.87 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
INVA previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
INVA next earnings announcement is scheduled for Feb 28, 2025

Related metrics

Annual Total Expenses

$196.58 M
INVA annual total expenses is $196.58 million

Annual Operating Expenses

$153.94 M
INVA annual total operating expenses is $153.94 million

TTM Cost Of Goods Sold

$42.56 M
INVA TTM cost of goods sold is $42.56 million

TTM Interest Expense

$23.41 M
INVA TTM interest expense is $23.41 million

INVA Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+290.3%0.0%+33.9%
3 y3 years+100.0%+162.8%+100.0%
5 y5 years+57.0%+96.1%+87.7%

INVA Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-100.0%at high+162.8%at high+392.2%
5 y5-yearat high-100.0%at high+162.7%at high+392.2%
alltimeall timeat high-100.0%at high+162.7%at high+392.2%

Innoviva Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sep 2024
-
$6.51 M(+1.1%)
$25.90 M(0.0%)
Jun 2024
-
$6.44 M(0.0%)
$25.90 M(+6.1%)
Mar 2024
-
$6.44 M(-1.1%)
$24.42 M(+12.1%)
Dec 2023
$21.78 M(+290.3%)
$6.51 M(-0.0%)
$21.78 M(+12.6%)
Sep 2023
-
$6.51 M(+31.3%)
$19.34 M(+34.9%)
Jun 2023
-
$4.96 M(+30.3%)
$14.34 M(+52.8%)
Mar 2023
-
$3.81 M(-6.5%)
$9.39 M(+68.2%)
Dec 2022
$5.58 M(>+9900.0%)
$4.07 M(+169.4%)
$5.58 M(-163.0%)
Sep 2022
-
$1.51 M(>+9900.0%)
-$8.87 M(+28.1%)
Jun 2022
-
$0.00(0.0%)
-$6.92 M(+99.9%)
Mar 2022
-
$0.00(-100.0%)
-$3.46 M(<-9900.0%)
Dec 2021
$0.00(0.0%)
-$10.38 M(-400.1%)
$0.00(-100.0%)
Sep 2021
-
$3.46 M(0.0%)
-$6000.00(+100.0%)
Jun 2021
-
$3.46 M(-0.1%)
-$3000.00(0.0%)
Mar 2021
-
$3.46 M(-133.3%)
-$3000.00(<-9900.0%)
Dec 2020
$0.00(-100.0%)
-$10.38 M(-400.0%)
$0.00(-100.0%)
Sep 2020
-
$3.46 M(+0.1%)
$13.86 M(+1.0%)
Jun 2020
-
$3.46 M(-0.1%)
$13.71 M(-0.6%)
Mar 2020
-
$3.46 M(-0.3%)
$13.80 M(-0.5%)
Dec 2019
$13.87 M(+0.0%)
$3.47 M(+4.6%)
$13.87 M(+0.0%)
Sep 2019
-
$3.32 M(-6.2%)
$13.87 M(-1.1%)
Jun 2019
-
$3.54 M(+0.1%)
$14.02 M(+0.5%)
Mar 2019
-
$3.54 M(+2.0%)
$13.94 M(+0.5%)
Dec 2018
$13.87 M(-0.8%)
$3.47 M(0.0%)
$13.87 M(-0.2%)
Sep 2018
-
$3.47 M(0.0%)
$13.90 M(-0.2%)
Jun 2018
-
$3.47 M(0.0%)
$13.93 M(-0.2%)
Mar 2018
-
$3.47 M(-0.8%)
$13.95 M(-0.2%)
Dec 2017
$13.98 M(+0.2%)
$3.50 M(-0.0%)
$13.98 M(-0.0%)
Sep 2017
-
$3.50 M(+0.0%)
$13.98 M(+0.0%)
Jun 2017
-
$3.50 M(-0.0%)
$13.98 M(+0.1%)
Mar 2017
-
$3.50 M(0.0%)
$13.97 M(+0.1%)
Dec 2016
$13.95 M(+0.2%)
$3.50 M(+0.1%)
$13.95 M(+0.1%)
Sep 2016
-
$3.49 M(+0.2%)
$13.94 M(+0.1%)
Jun 2016
-
$3.48 M(+0.0%)
$13.93 M(+0.0%)
Mar 2016
-
$3.48 M(-0.0%)
$13.93 M(0.0%)
Dec 2015
$13.93 M(+14.4%)
$3.48 M(+0.0%)
$13.93 M(+0.2%)
Sep 2015
-
$3.48 M(0.0%)
$13.90 M(+7.4%)
Jun 2015
-
$3.48 M(0.0%)
$12.95 M(-0.5%)
Mar 2015
-
$3.48 M(+0.8%)
$13.02 M(+6.9%)
Dec 2014
$12.18 M
$3.46 M(+36.6%)
$12.18 M(+19.1%)
Sep 2014
-
$2.53 M(-28.8%)
$10.22 M(+34.2%)
DateAnnualQuarterlyTTM
Jun 2014
-
$3.55 M(+34.6%)
$7.61 M(+81.3%)
Mar 2014
-
$2.64 M(+76.0%)
$4.20 M(+21.4%)
Dec 2013
$3.46 M(+6.4%)
$1.50 M(-2046.8%)
$3.46 M(-1472.2%)
Sep 2013
-
-$77.00 K(-155.8%)
-$252.00 K(-114.7%)
Jun 2013
-
$138.00 K(-92.7%)
$1.72 M(-47.1%)
Mar 2013
-
$1.90 M(-185.8%)
$3.24 M(-0.4%)
Dec 2012
$3.25 M(-57.1%)
-$2.21 M(-217.0%)
$3.25 M(-57.1%)
Sep 2012
-
$1.89 M(+13.7%)
$7.59 M(-2.1%)
Jun 2012
-
$1.66 M(-13.0%)
$7.75 M(-1.2%)
Mar 2012
-
$1.91 M(-10.1%)
$7.84 M(+3.4%)
Dec 2011
$7.58 M(+19.7%)
$2.12 M(+3.5%)
$7.58 M(+6.8%)
Sep 2011
-
$2.05 M(+16.8%)
$7.10 M(+7.4%)
Jun 2011
-
$1.76 M(+6.5%)
$6.61 M(+2.1%)
Mar 2011
-
$1.65 M(+0.7%)
$6.47 M(+2.1%)
Dec 2010
$6.34 M(+14.3%)
$1.64 M(+5.1%)
$6.34 M(+2.0%)
Sep 2010
-
$1.56 M(-3.8%)
$6.21 M(+1.0%)
Jun 2010
-
$1.62 M(+7.1%)
$6.15 M(+5.1%)
Mar 2010
-
$1.51 M(0.0%)
$5.85 M(+5.6%)
Dec 2009
$5.54 M(-20.4%)
$1.51 M(+1.2%)
$5.54 M(+5.7%)
Sep 2009
-
$1.50 M(+13.1%)
$5.24 M(-1.7%)
Jun 2009
-
$1.32 M(+9.9%)
$5.33 M(-15.7%)
Mar 2009
-
$1.21 M(-1.1%)
$6.33 M(-9.1%)
Dec 2008
$6.96 M(+71.6%)
$1.22 M(-23.3%)
$6.96 M(-4.3%)
Sep 2008
-
$1.59 M(-31.5%)
$7.28 M(+11.6%)
Jun 2008
-
$2.32 M(+26.1%)
$6.52 M(+29.8%)
Mar 2008
-
$1.84 M(+19.9%)
$5.03 M(+23.8%)
Dec 2007
$4.06 M(-3.3%)
$1.53 M(+83.8%)
$4.06 M(+11.6%)
Sep 2007
-
$834.00 K(+1.7%)
$3.63 M(-5.5%)
Jun 2007
-
$820.00 K(-5.9%)
$3.85 M(-7.7%)
Mar 2007
-
$871.00 K(-21.5%)
$4.17 M(-0.6%)
Dec 2006
$4.20 M(+2.2%)
$1.11 M(+6.0%)
$4.20 M(+2.3%)
Sep 2006
-
$1.05 M(-8.4%)
$4.10 M(+0.3%)
Jun 2006
-
$1.14 M(+27.3%)
$4.09 M(+4.4%)
Mar 2006
-
$898.00 K(-11.5%)
$3.92 M(-4.6%)
Dec 2005
$4.11 M(-14.7%)
$1.01 M(-1.9%)
$4.11 M(+32.8%)
Sep 2005
-
$1.03 M(+6.6%)
$3.09 M(+50.3%)
Jun 2005
-
$971.00 K(-10.6%)
$2.06 M(+89.4%)
Mar 2005
-
$1.09 M
$1.09 M
Dec 2004
$4.81 M(-7.6%)
-
-
Dec 2003
$5.21 M(+1.7%)
-
-
Dec 2002
$5.12 M
-
-

FAQ

  • What is Innoviva annual depreciation & amortization?
  • What is the all time high annual D&A for Innoviva?
  • What is Innoviva annual D&A year-on-year change?
  • What is Innoviva quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Innoviva?
  • What is Innoviva quarterly D&A year-on-year change?
  • What is Innoviva TTM depreciation & amortization?
  • What is the all time high TTM D&A for Innoviva?
  • What is Innoviva TTM D&A year-on-year change?

What is Innoviva annual depreciation & amortization?

The current annual D&A of INVA is $21.78 M

What is the all time high annual D&A for Innoviva?

Innoviva all-time high annual depreciation & amortization is $21.78 M

What is Innoviva annual D&A year-on-year change?

Over the past year, INVA annual depreciation & amortization has changed by +$16.20 M (+290.32%)

What is Innoviva quarterly depreciation & amortization?

The current quarterly D&A of INVA is $6.51 M

What is the all time high quarterly D&A for Innoviva?

Innoviva all-time high quarterly depreciation & amortization is $6.51 M

What is Innoviva quarterly D&A year-on-year change?

Over the past year, INVA quarterly depreciation & amortization has changed by $0.00 (0.00%)

What is Innoviva TTM depreciation & amortization?

The current TTM D&A of INVA is $25.90 M

What is the all time high TTM D&A for Innoviva?

Innoviva all-time high TTM depreciation & amortization is $25.90 M

What is Innoviva TTM D&A year-on-year change?

Over the past year, INVA TTM depreciation & amortization has changed by +$6.56 M (+33.90%)